Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Polley

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
American Journal of Human Genetics|February 20, 2021
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceMarcy E Richardson, Chunling Hu, Kun Y Lee, et al.
Science Translational Medicine|December 22, 2021
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.
BMJ Open Diabetes Research & Care|May 21, 2026
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.
JACC. Advances|June 28, 2024
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesRozalina G McCoy, Kavya Sindhu Swarna, Yihong Deng, et al.
Cancer Research|July 17, 2013
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacologyOgan D Abaan, Eric C Polley, Sean R Davis, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2016
Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing AssaysDavid J Sims, Robin D Harrington, Eric C Polley, et al.
Nature Cardiovascular Research|June 7, 2024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular riskRozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic AdenocarcinomaSiddhartha Yadav, Pashtoon M Kasi, William R Bamlet, et al.
Journal of the American Heart Association|May 14, 2026
Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target TrialAnum Zehra, Yihong Deng, Kavya Sindhu Swarna, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
American Journal of Human Genetics|February 20, 2021
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceMarcy E Richardson, Chunling Hu, Kun Y Lee, et al.
Science Translational Medicine|December 22, 2021
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.
BMJ Open Diabetes Research & Care|May 21, 2026
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.
JACC. Advances|June 28, 2024
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesRozalina G McCoy, Kavya Sindhu Swarna, Yihong Deng, et al.
Cancer Research|July 17, 2013
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacologyOgan D Abaan, Eric C Polley, Sean R Davis, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2016
Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing AssaysDavid J Sims, Robin D Harrington, Eric C Polley, et al.
Nature Cardiovascular Research|June 7, 2024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular riskRozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic AdenocarcinomaSiddhartha Yadav, Pashtoon M Kasi, William R Bamlet, et al.
Journal of the American Heart Association|May 14, 2026
Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target TrialAnum Zehra, Yihong Deng, Kavya Sindhu Swarna, et al.
Pageof 12